Data on depression suggest possibility of personalized treatments

February 23, 2017 by Bill Hathaway, Yale University
Data on depression suggest possibility of personalized treatments
Credit: Michael S. Helfenbein

Depression is a complex disorder, characterized by clusters of symptoms that respond to treatment with varying degrees of success and are likely to reoccur after initial remission. However, a group of Yale researchers, combing through data on 9,000 depressed patients, found evidence that it may be possible to develop personalized treatments and maintain a successful clinical response, they report in two separate studies published this month.

"We know that can experience depression in very different ways, and they may not even have many symptoms in common," said Adam Chekroud, a doctoral student in the Yale Department of Psychology and lead author of the latest study published Feb. 22 in the journal JAMA Psychiatry. "We wanted to know whether antidepressants work well on all of these different symptoms, or whether they are better suited to some than others."

The study found effects of antidepressants varied among patients, depending upon their symptoms. For instance, one drug might work well for symptoms of low mood or feelings of anxiety, but not on "atypical" symptoms, such as thoughts of suicide or cognitive impairments like an inability to concentrate. Using questionnaires filled out by doctors and patients, the researchers were able to identify clusters of symptoms that emerged in different trials. The group used advanced statistical analysis to determine which antidepressants worked best for different sets of symptoms.

"Different symptoms of depression may have different underlying biologies and may dictate distinct kinds of treatments," said Dr. John Krystal, the Robert L. McNeil Jr. Professor of Translational Research and Professor of Psychiatry and of Neuroscience. "This method may allow doctors to help optimize medication treatments for individuals."

"Patients who undergo treatment may believe that medications work for everyone and that when you get better you will stay better," said Krystal. "But in the real world, treatment of depression is a roller coaster ride."

Only about 20% of patients who continue to take antidepressants will stay in remission, and 47% of patients continue to show some instability in their mood. And one out of every three of patients were at high risk of relapsing into depression. The researchers found that the risk of relapse was particularly high among women, who were 59% more likely than men to have a recurrence of depressive . Those who continued to take were only slightly better off than those who discontinued use.

"Although there was an advantage for patients who continued taking medications, it is clear that we need to think about additional strategies to maintain remission in patients once they recover from an episode of ," said Ralitza Gueorguieva, senior research scientist in biostatistics and first author of the paper about relapse published Feb. 13 in the journal Lancet Psychiatry.

Explore further: Antidepressant side effects reported more by patients with co-occurring panic disorder

More information: Ralitza Gueorguieva et al. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis, The Lancet Psychiatry (2017). DOI: 10.1016/S2215-0366(17)30038-X

Related Stories

Antidepressant side effects reported more by patients with co-occurring panic disorder

January 4, 2017
Patients who take medication for depression report more side effects if they also suffer from panic disorder, according to a new study led by researchers from the University of Illinois at Chicago published in the Journal ...

Work productivity is key factor in assessing recovery of depressed patients

August 15, 2016
While medications can quickly reduce depressive symptoms, monitoring work productivity can provide unique insight into whether a patient will require additional treatments to achieve long-term remission, a new study through ...

Changes in depression symptoms tied to mortality in lung cancer

October 7, 2016
(HealthDay)—Longitudinal changes in depression are associated with differences in mortality among patients with lung cancer, according to a study published online Oct. 3 in the Journal of Clinical Oncology.

Depression too often reduced to a checklist of symptoms

October 23, 2015
How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) - the 'bible' of psychiatry - diagnoses depression when patients tick off a certain number of symptoms on the DSM checklist. ...

MRI scans could predict patients at risk of major depressive disorder

October 8, 2015
Functional magnetic resonance imaging (fMRI) could be used to predict which patients with recovered major depressive disorder are most likely to have more depressive episodes, according to a study published today in JAMA ...

Antidepressants beneficial for women with postnatal depression

May 19, 2015
Antidepressants are associated with better rates of treatment response and remission for women with postnatal depression, when compared to a placebo, according to a new systematic review by the Institute of Psychiatry, Psychology ...

Recommended for you

Color of judo uniform has no effect on winning

February 22, 2018
New research on competitive judo data finds a winning bias for the athlete who is first called, regardless of the colour of their uniform. This unique study, published in Frontiers in Psychology, puts to rest the debate on ...

Infants are able to learn abstract rules visually

February 22, 2018
Three-month-old babies cannot sit up or roll over, yet they are already capable of learning patterns from simply looking at the world around them, according to a recent Northwestern University study published in PLOS One.

Antidepressants are more effective than placebo at treating acute depression in adults, concludes study

February 22, 2018
Meta-analysis of 522 trials includes the largest amount of unpublished data to date, and finds that antidepressants are more effective than placebo for short-term treatment of acute depression in adults.

Smartphones are bad for some teens, not all

February 21, 2018
Is the next generation better or worse off because of smartphones? The answer is complex and research shows it largely depends on their lives offline.

Researchers uncover novel mechanism behind schizophrenia

February 21, 2018
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein—neuregulin 3—controls how key neurotransmitters are released ...

Self-compassion may protect people from the harmful effects of perfectionism

February 21, 2018
Relating to oneself in a healthy way can help weaken the association between perfectionism and depression, according to a study published February 21, 2018 in the open-access journal PLOS ONE by Madeleine Ferrari from Australian ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

LaPortaMA
not rated yet Mar 16, 2017
Write this down:
by no means is "personalized" the same as "personal."

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.